Jacob van Naarden, Chief Business Officer at Loxo Oncology, Inc. (LOXO), sold 2,119 shares at $138.08 ($293K) on 2018-11-27, disclosed to the SEC on 2018-11-28.
Open-market sale of $293k LOXO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.08 | 949 | $131K | 44.7% |
| 2 | $138.83 | 1,170 | $162K | 55.3% |
| Total | $138.49 avg | 2,119 | $293K | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $426K | — | Filing → |
| LOXO | SELL | 2018-12-12 | $120K | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.5M | — | Filing → |